Stockscreener 앱 받기
11.06
0.91%
0.10
전일 마감가:
$10.96
열려 있는:
$11.13
하루 거래량:
841.55K
Relative Volume:
0.44
시가총액:
$1.59B
수익:
-
순이익/손실:
$-174.61M
주가수익비율:
-5.6142
EPS:
-1.97
순현금흐름:
$-165.54M
1주 성능:
+4.64%
1개월 성능:
+68.09%
6개월 성능:
+24.27%
1년 성능:
+5.74%
1일 변동 폭
$10.88
$11.23
1주일 범위
$10.50
$11.31
52주 변동 폭
$5.9857
$16.63
89 Bio Inc Stock (ETNB) Company Profile
명칭
89 Bio Inc
전화
(415) 432-9270
주소
142 SANSOME STREET, SAN FRANCISCO, CA
ETNB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
11.06 | 1.59B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-04-22 | 재개 | BofA Securities | Buy |
| 2024-01-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2023-08-28 | 개시 | UBS | Buy |
| 2023-06-13 | 개시 | Evercore ISI | Outperform |
| 2022-05-12 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-26 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-19 | 개시 | Raymond James | Strong Buy |
| 2020-09-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-07-23 | 개시 | BTIG Research | Buy |
| 2020-07-07 | 개시 | Chardan Capital Markets | Buy |
| 2019-12-09 | 개시 | BofA/Merrill | Neutral |
| 2019-12-09 | 개시 | Oppenheimer | Outperform |
| 2019-12-09 | 개시 | RBC Capital Mkts | Outperform |
| 2019-12-09 | 개시 | SVB Leerink | Outperform |
모두보기
89 Bio Inc 주식(ETNB)의 최신 뉴스
89bio, Inc. (NASDAQ:ETNB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Weiss Ratings Reiterates Sell (D-) Rating for 89bio (NASDAQ:ETNB) - Defense World
89bio (NASDAQ:ETNB) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
89bio Inc (NASDAQ: ETNB) Is A Buzzing Hot Stock - Stocks Register
89bio, Inc. (NASDAQ:ETNB) Shares Sold by abrdn plc - MarketBeat
89bio (NASDAQ:ETNB) Shares Up 7.1%Time to Buy? - MarketBeat
FY2024 Earnings Estimate for 89bio Issued By Leerink Partnrs - MarketBeat
ETNB89bio, Inc. Latest Stock News & Market Updates - StockTitan
Recent uptick might appease Cabaletta Bio, Inc. (NASDAQ:CABA) institutional owners after losing 89% over the past year - Simply Wall St
Ra Capital Management, L.P. Buys 5,714,285 Shares of 89bio, Inc. (NASDAQ:ETNB) Stock - MarketBeat
89bio Inc [ETNB] stock for 49,999,994 USD was acquired by RA CAPITAL MANAGEMENT, L.P. - Knox Daily
89bio (NASDAQ:ETNB) Coverage Initiated by Analysts at Wolfe Research - MarketBeat
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Inside 89bio's Latest Executive Compensation Move: 163K Share Options Granted - StockTitan
Institutional investors have a lot riding on 89bio, Inc. (NASDAQ:ETNB) with 58% ownership - Yahoo Finance
SG Americas Securities LLC Has $284,000 Stock Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Wolfe Research Initiates Coverage on 89bio (NASDAQ:ETNB) - Defense World
What is Leerink Partnrs’ Forecast for 89bio FY2024 Earnings? - Defense World
89bio Inc [ETNB] gain 37.47% so far this year. What now? - The DBT News
89bio Inc (ETNB)’s Market Momentum: Closing Strong at 10.75, Up 15.72 - The Dwinnex
What is Leerink Partnrs’ Estimate for 89bio FY2029 Earnings? - Defense World
Wolfe Research Initiates Coverage of 89bio (ETNB) with Outperform Recommendation - MSN
89bio CEO awarded 200,000 restricted stock units By Investing.com - Investing.com Australia
89bio CEO awarded 200,000 restricted stock units - MSN
89bio Inc (NASDAQ: ETNB) Is Expected To Soar To Higher Prices In The Months To Come. - Marketing Sentinel
ETNB’s Financial Health: Exploring 89bio Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
Hedge Fund and Insider Trading News: Ken Griffin, Paul Singer, Greenlight Capital, Balyasny Asset Management, Ashland Inc (ASH), 89bio Inc (ETNB), and More - Insider Monkey
Wall Street Analysts Think 89BIO (ETNB) Could Surge 219.06%: Read This Before Placing a Bet - MSN
FY2029 Earnings Forecast for 89bio Issued By Leerink Partnrs - MarketBeat
ETNB Insider Trade Alert! Majority Shareholder Sells $50M Worth of 89bio Stock - TipRanks
89bio, Inc. (NASDAQ:ETNB) Short Interest Up 12.2% in January - MarketBeat
89bio (NASDAQ:ETNB) Receives Sell (D-) Rating from Weiss Ratings - Defense World
89bio Stock Upgraded to Buy: Positive SYMMETRY Study Data Reinforces FGF21 Analog Potential - TipRanks
RA CAPITAL MANAGEMENT, L.P. Increases Stake in 89bio Inc - GuruFocus.com
Major Investment Alert: 89bio Stock Sees Multi-Million Dollar Boost! - TipRanks
Leerink raises 89bio stock target to $37 on NASH study optimism - Investing.com Canada
89bio Inc [ETNB] Insider Activity: An Update for Investors - Knox Daily
89bio Closes Public Offering, Raises $287.5 Mln - Nasdaq
89bio Closes $287.5 Million Public Offering -February 03, 2025 at 11:17 am EST - Marketscreener.com
89bio Announces Closing of its Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - The Manila Times
89bio Secures Massive $287.5M Capital Injection: What This Means for NASH Treatment Future - StockTitan
Leerink raises 89bio stock target to $37 on NASH study optimism By Investing.com - Investing.com South Africa
89bio (NASDAQ:ETNB) Price Target Raised to $38.00 - Defense World
89bio (NASDAQ:ETNB) Shares Gap UpHere's Why - MarketBeat
UBS Group Issues Positive Forecast for 89bio (NASDAQ:ETNB) Stock Price - MarketBeat
89bio (NASDAQ:ETNB) Trading Up 8.3%Here's What Happened - MarketBeat
89bio (NASDAQ:ETNB) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
89bio's SWOT analysis: pegozafermin's potential in MASH and SHTG markets - Investing.com
89bio Inc (ETNB) Offers An Excellent Investment Opportunity At Current Levels - Stocks Register
89bio’s Pegozafermin Is Now Gaining Momentum (NASDAQ:ETNB) - Seeking Alpha
MASH momentum prompts $250 million raise for 89bio - The Pharma Letter
89 Bio Inc (ETNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
89 Bio Inc 주식 (ETNB) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| McWherter Charles | Director |
Jan 22 '25 |
Buy |
6.71 |
10,000 |
67,100 |
25,000 |
| McWherter Charles | Director |
Jan 21 '25 |
Buy |
6.55 |
5,000 |
32,750 |
15,000 |
| Le-Nguyen Quoc | See Remarks |
Jan 15 '25 |
Sale |
6.49 |
10,963 |
71,150 |
271,833 |
0.27%
3.05%
자본화:
|
볼륨(24시간):